Document is current
Any future updates will be listed below
-
Authors
Chauvin, Samuel D.
Holley, Joe A.
Poddar, Subhajit
Miner, Cathrine A.
Kumble, Lindsay
Fu, Jiayuan
Laue-Gizzi, Hanka
Hardy, Todd A.
Miner, Jonathan J.
-
Funding
Funding for this research was provided by:
Clayco Foundation (No Number)
Colton Center for Autoimmunity (No Number)
NIH (R01AI143982)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 5 December 2024
First Online: 13 December 2024
Declarations
:
: Dr. Jonathan Miner and the University of Pennsylvania Perelman School of Medicine hold the provisional patent for the RVCL gene therapy, described in this manuscript.
